mRNA vaccine
mRNA vaccine
Agilent’s $925M Biovectra Buy: Boosting Growth!
BIOT
Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦
Revolutionizing mRNA Vaccines: Faster Scalable and Effective!
BIOT
📚 Advancing mRNA Vaccine and Therapy Development discusses progress in mRNA vaccines and therapies, highlighting cell-free cloning for gene synthesis. 🧬💉
